Opportunity Overview
Using viral and replicon systems we will utilise saturating mutagenesis within the hypervariable region (HVR) of the HEV genome. We can then insert the replicon RNA into human and porcine cells and compare the replication abilities using fluorescence tagging and live cell imaging. These efforts will initially focus on Genotype 3 as the literature suggests Genotype 1 is not replication competent in porcine cell lines. However, once controls are established, there is scope to mutate and compare the HVR of Genotype 1 to establish which areas permit cross species replication of HEV and related viruses.
This is one of 1,831 active United Kingdom Research Development opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | BBSRC |
|---|---|
| Country | United Kingdom |
| Category | Research Development |
| Published | September 30, 2024 |
| Procurement stage | Active solicitation |
| Response due | September 29, 2028 |
| Status | Open — accepting responses |
| Official source | View original notice |
| Last verified | August 12, 2026 |
Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.
Related Opportunities in United Kingdom
See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United Kingdom Research Development intelligence report in your inbox
A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.